Christensen, J.F.M.M.; Jürgens-Lahnstein, J.H.; Iljazi, A.; Andersen, S.E.; Dahl, M.; Jürgens, G.
Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study. Pharmaceuticals 2024, 17, 1373.
https://doi.org/10.3390/ph17101373
AMA Style
Christensen JFMM, Jürgens-Lahnstein JH, Iljazi A, Andersen SE, Dahl M, Jürgens G.
Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study. Pharmaceuticals. 2024; 17(10):1373.
https://doi.org/10.3390/ph17101373
Chicago/Turabian Style
Christensen, Johan Frederik Mebus Meyer, Jonathan Hugo Jürgens-Lahnstein, Afrim Iljazi, Stig Ejdrup Andersen, Morten Dahl, and Gesche Jürgens.
2024. "Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study" Pharmaceuticals 17, no. 10: 1373.
https://doi.org/10.3390/ph17101373
APA Style
Christensen, J. F. M. M., Jürgens-Lahnstein, J. H., Iljazi, A., Andersen, S. E., Dahl, M., & Jürgens, G.
(2024). Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study. Pharmaceuticals, 17(10), 1373.
https://doi.org/10.3390/ph17101373